总时间（秒）：10.80
问答时间（秒）：9.07

```json
{
  "Variants Include": [
    {
      "Gene": "DJ1",
      "variants": [
        {
          "HGVS": "NM_001169738.1:c.192G4C",
          "cDNA Change": {
            "transcript": "NM_001169738.1",
            "ref": "G",
            "alt": "C",
            "position": "192"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "D",
            "position": "64"
          },
          "Description in input context": "c.192G4C (p.E64D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0003633"
  },
  "Experiment Method": [
    {
      "Assay Method": "PET/CT",
      "Material used": {
        "Material Source": "Patients",
        "Material Name": "Patients",
        "Description": "The study utilized PET/CT imaging on 104 EOPD patients."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001169738.1:c.192G4C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "A substantial reduction of dopamine uptake transporter (DAT) binding was found in the striatum using [ 18 F]FP-CIT and PET, indicating a serious loss of presynaptic dopaminergic afferents.",
          "Protein Change": {
            "ref": "E",
            "alt": "D",
            "position": "64"
          }
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Source": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes",
        "Source": "N.D."
      }
    }
  ]
}
```